Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
wsu, COVID-19 vaccine and Eastern Washington Eagles football
Nick Rolovich loses lawsuit vs. WSU after being fired for refusing COVID vaccine
Former WSU football coach Nick Rolovich lost his lawsuit against the university that stemmed from his firing for refusing to get the COVID-19 vaccine.
Judge rules WSU justified in firing former football coach who refused COVID-19 vaccine
The decision from Judge Thomas Rice of the U.S. District Court for Eastern Washington comes three years after Rolovich was let go midway through the 2021 season. At the time, state employees were mandated to be vaccinated against the coronavirus, a requirement later rescinded by the state.
Court rules against former WSU football coach in vaccine mandate dispute
PULLMAN, Wash. — Former Washington State University (WSU) head football coach Nicholas Rolovich has lost his lawsuit against the university. On Monday, the U.S. District Court for the Eastern District of Washington ruled in favor of WSU, upholding Rolovich's termination for refusing to comply with the university’s COVID-19 vaccine mandate.
WSU wins lawsuit filed by former football coach Nick Rolovich over vaccine mandate
The lawsuit stemmed from WSU’s termination of Rolovich in December 2021 after he refused to get vaccinated against COVID-19 and his request for a religious exemption was denied. Rolovich claimed the university violated Title VII of the Civil Rights Act,
WSU had 'just cause' to fire former football coach Nick Rolovich, court finds
Three years after Washington State University fired its head football coach, a federal court has said the university had the right to do so.
19m
What COVID tried to teach us — and why it will matter in the next pandemic
The intervening years have both sped and crawled by, too busy at times to take stock of all that has changed, too plodding to ...
12h
Covid vaccine scientists develop bubonic plague jab ahead of "next pandemic"
The team behind the Oxford AstraZeneca covid vaccine say they are developing an injection that could prevent the bubonic ...
6m
on MSN
Pittsburgh area seeing uptick in flu, norovirus, COVID-19 and RSV cases
RSV and norovirus are making the rounds in the aftermath of holiday gatherings. Just in time to get back in the swing of work ...
Verywell Health on MSN
6h
Flu, COVID, and RSV: Flu Is Driving a Surge of Illness in Most States
Fact checked by Nick Blackmer Flu and COVID-19 case counts are high and rising in most parts of the United States, according ...
WESA
13h
Penn expecting $467M windfall from COVID-19 vaccine royalty dispute
The University of Pennsylvania expects to receive $467 million from a German
COVID
-19
vaccine
manufacturer after the pair ...
13h
Why The U.S. Could Be Making The Same Mistakes With Bird Flu As It Did With COVID-19
The first severe human case of bird flu was recently reported in the U.S. Here are some ways the U.S. may be repeating the ...
3d
on MSN
5 things we know and still don’t know about COVID, 5 years after it appeared
Five years after the virus that causes COVID emerged in China it still holds some mysteries. The disease has killed an ...
14h
Long COVID Breakthrough: Spike Proteins Persist in Brain for Years
Researchers have discovered that the SARS-CoV-2 spike protein persists in the brain and skull bone marrow for years after ...
3h
Austal Workers Advance Religious Bias Claims Over Covid Jab Rule
Austal USA LLC failed to show granting 56 employees religious exemptions from its Covid-19 vaccine mandate necessarily would ...
5h
on MSN
HMPV and COVID-19: Similarities, differences, and is there a vaccine?
The outbreak of Human Metapneumovirus (HMPV) in China has raised international alarm, evoking comparisons to the COVID-19 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
HMPV
Human metapneumovirus
China
United States
Feedback